相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Novel HAGE/WT1-ImmunoBody(R) Vaccine Combination Enhances Anti-Tumour Responses When Compared to Either Vaccine Alone
Rukaia Almshayakhchi et al.
FRONTIERS IN ONCOLOGY (2021)
Prognostic value of CD8+PD-1+immune infiltrates and PDCD1 gene expression in triple negative breast cancer
Joe Yeong et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Atezolizumab Plus nab-Paclitaxel in the Treatment of Metastatic Triple-Negative Breast Cancer With 2-Year Survival Follow-up A Phase 1b Clinical Trial
Sylvia Adams et al.
JAMA ONCOLOGY (2019)
Sequential administration of MVA-based vaccines and PD-1/PD-L1-blocking antibodies confers measurable benefits on tumor growth and survival: Preclinical studies with MVA-Gal and MVA-MUC1 (TG4010) in a murine tumor model
Christelle Remy-Ziller et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Concurrent, but not sequential, PD-1 blockade with a DNA vaccine elicits anti-tumor responses in patients with metastatic, castration-resistant prostate cancer
Douglas G. McNeel et al.
Oncotarget (2018)
Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trial
Poulam M. Patel et al.
ONCOIMMUNOLOGY (2018)
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2018)
An overview of triple-negative breast cancer
Pankaj Kumar et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2016)
HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression Analysis
Tarek M. A. Abdel-Fatah et al.
CLINICAL CANCER RESEARCH (2016)
SCIB1, a huIgG1 antibody DNA vaccination, combined with PD-1 blockade induced efficient therapy of poorly immunogenic tumors
Wei Xue et al.
ONCOTARGET (2016)
SCIB2, an antibody DNA vaccine encoding NY-ESO-1 epitopes, induces potent antitumor immunity which is further enhanced by checkpoint blockade
Wei Xue et al.
ONCOIMMUNOLOGY (2016)
Adjuvants for peptide-based cancer vaccines
Hiep Khong et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Trial Watch: Peptide-based anticancer vaccines
Jonathan Pol et al.
ONCOIMMUNOLOGY (2015)
A quantitative analysis of therapeutic cancer vaccines in phase 2 or phase 3 trial
Amabel C. L. Tan et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)
PD-L1 Expression in Triple-Negative Breast Cancer
Elizabeth A. Mittendorf et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Molecular Heterogeneity of Triple-Negative Breast Cancer
Vandana G. Abramson et al.
CURRENT BREAST CANCER REPORTS (2014)
Phase I trial of ImmunoBody in melanoma patients.
Poulam M. Patel et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activation
Rodney A. Rosalia et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer
Satoshi Wada et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion
Yared Hailemichael et al.
NATURE MEDICINE (2013)
Vaccination-induced functional competence of circulating human tumor-specific CD8 T-cells
Petra Baumgaertner et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
The Helicase HAGE Expressed by Malignant Melanoma-Initiating Cells Is Required for Tumor Cell Proliferation in Vivo
Adam J. Linley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Adjuvants for Enhancing the Immunogenicity of Whole Tumor Cell Vaccines
Cheryl Lai-Lai Chiang et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2011)
DNA vaccination with T-cell epitopes encoded within Ab molecules induces high-avidity anti-tumor CD8+ T cells
Victoria A. Pudney et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Antibodies designed as effective cancer vaccines
R. L. Metheringham et al.
MABS (2009)
CpG oligodeoxynucleotides alter lymphocyte and dendritic cell trafficking in humans
W. Nicholas Haining et al.
CLINICAL CANCER RESEARCH (2008)
Immunotherapy of established (pre) malignant disease by synthetic long peptide vaccines
Cornelis J. M. Melief et al.
NATURE REVIEWS CANCER (2008)
HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptides
Morgan G. Mathieu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
CD8+ CTL priming by exact peptide epitopes in incomplete Freund's adjuvant induces a vanishing CTL response, whereas long peptides induce sustained CTL reactivity
Martijn S. Bijker et al.
JOURNAL OF IMMUNOLOGY (2007)
Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming
Danila Valmori et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Analysis of the tumour suppressor genes, FHIT and WT-1, and the tumour rejection genes, BAGE, GAGE-1/2, HAGE, MAGE-1, and MAGE-3, in benign and malignant neoplasms of the salivary glands
H Nagel et al.
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY (2003)
分享论文
